Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 22% ± 7% | |
| glutamatergic neuron | 3 studies | 26% ± 8% | |
| dendritic cell | 3 studies | 26% ± 5% | |
| transit amplifying cell | 3 studies | 33% ± 7% | |
| astrocyte | 3 studies | 21% ± 3% | |
| oligodendrocyte | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 21% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1235.40 | 1445 / 1445 | 100% | 14.78 | 183 / 183 |
| lung | 100% | 944.49 | 577 / 578 | 100% | 9.70 | 1151 / 1155 |
| intestine | 100% | 1156.91 | 966 / 966 | 99% | 11.00 | 524 / 527 |
| stomach | 100% | 862.39 | 358 / 359 | 99% | 11.32 | 284 / 286 |
| bladder | 100% | 1198.14 | 21 / 21 | 99% | 10.23 | 498 / 504 |
| ovary | 100% | 896.05 | 180 / 180 | 99% | 7.84 | 424 / 430 |
| breast | 100% | 1053.94 | 459 / 459 | 98% | 9.63 | 1092 / 1118 |
| skin | 100% | 1592.41 | 1809 / 1809 | 98% | 11.06 | 461 / 472 |
| uterus | 100% | 1043.89 | 170 / 170 | 97% | 11.19 | 447 / 459 |
| pancreas | 100% | 632.13 | 327 / 328 | 94% | 5.75 | 168 / 178 |
| thymus | 100% | 1086.43 | 653 / 653 | 93% | 5.01 | 563 / 605 |
| prostate | 100% | 952.39 | 245 / 245 | 88% | 3.90 | 441 / 502 |
| kidney | 100% | 706.33 | 89 / 89 | 88% | 4.11 | 790 / 901 |
| adrenal gland | 100% | 1318.61 | 258 / 258 | 69% | 3.19 | 158 / 230 |
| brain | 83% | 397.58 | 2190 / 2642 | 81% | 3.81 | 573 / 705 |
| liver | 72% | 233.14 | 162 / 226 | 40% | 1.83 | 161 / 406 |
| adipose | 100% | 961.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1384.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.38 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.59 | 1 / 1 |
| blood vessel | 100% | 957.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 830.82 | 784 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 13.23 | 28 / 29 |
| heart | 95% | 623.33 | 818 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 67% | 1841.61 | 623 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 2.46 | 51 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006353 | Biological process | DNA-templated transcription termination |
| GO_0006281 | Biological process | DNA repair |
| GO_0008380 | Biological process | RNA splicing |
| GO_0006397 | Biological process | mRNA processing |
| GO_0006369 | Biological process | termination of RNA polymerase II transcription |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0005829 | Cellular component | cytosol |
| GO_0008023 | Cellular component | transcription elongation factor complex |
| GO_0005681 | Cellular component | spliceosomal complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0140658 | Molecular function | ATP-dependent chromatin remodeler activity |
| GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
| GO_0004386 | Molecular function | helicase activity |
| GO_0016787 | Molecular function | hydrolase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | TTF2 |
| Protein name | Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2) Transcription termination factor 2 |
| Synonyms | |
| Description | FUNCTION: DsDNA-dependent ATPase which acts as a transcription termination factor by coupling ATP hydrolysis with removal of RNA polymerase II from the DNA template. May contribute to mitotic transcription repression. May also be involved in pre-mRNA splicing. . |
| Accessions | ENST00000369466.9 [Q9UNY4-1] ENST00000427271.1 X6RI15 Q9UNY4 |
